Cyto-colpo-histologic correlation: about an analytical study of 120 colposcopies.

##plugins.themes.academic_pro.article.sidebar##

Published May 19, 2017
Download
pdf
Vol. 94 No. 10 (2016): Issue Oct 2016

##plugins.themes.academic_pro.article.main##

Olfa Slimani
Riadh Ben Temim
Tahar Makhlouf
Nabil Mathlouthi
Leila Attia

Abstract

Problem: Cervical cancer is the second gynecological cancer Tunisian women after breast. This is a sexually transmitted disease including the role of HPV has been proven. Cervical cancer screening is possible due to the accessibility of the cervix with a speculum examination and implementation of cervical smear.
Aim of the work: To study the epidemiological and clinical data of patients, analyze the results of the Pap test, colposcopy and cervical biopsy staging are the lesions observed in colposcopy, compare the results of smears, colposcopy and cervical biopsy.
Methods: A retrospective analytical study about 120 observations of patients who underwent colposcopy and biopsy of the cervix over a seven year period from January 2006 to December 2012.
Results: The mean age of patients was 46.6 years. The mean gravidity was 4.99. The mean parity was 4.07. The average age of first sexual intercourse was 24 years. 95.83% of the patients were married. Four patients had multiple partners, 3, 33%. Eighty-one patients 67.5% were genital activity. Two patients had a history of pelvic infection is 1.66%. A history of repeated low genital infection were found in 20 patients, or 16.66%. HPV testing was requested for two patients. The genotypes found were 16, 35 and 53. The most
common reasons were essentially pathological smears, pelvic pain and exploration of bleeding. The FCU was performed in 98 patients either in 81.66% of cases. The smear was pathological in 83 patients or 84.69% of smears. He showed: a persistent inflammatory smears in 64 women, or 65.30% of the cases, 6 ASCUS or 6.12% of cases, 13 cervical dysplasia or 13.26% of cases: 8 CIN1 or 8.16% of event; 1 CIN2 or 1.02% and 4 CIN 3, or 4.08% of cases.
Colposcopy was indicated before an abnormal smear: In 83 patients either in 69.16% of cases. Colposcopy was performed in front of an abnormal appearance of the cervix in 37 patients. Colposcopy has concluded that: normal cervix in 28 patients or 23.33% of the cases, cervicitis appearance in 15 patients or 12.5% of cases, ectropion in 23 patients or 19.2% of cases, with TAGI 47 patients or 39.2% of cases, a TAG2 in 6 patients either 5% of cases, ulceration in a patient or 0.83% of cases. Cervical biopsy objectified normal mucosa in 19 patients, or 15.8% of cases. She objectified cervical metaplasia in 11 patients, or 9.2% of cases, ectropion in a patient, or 0.8% of cases, cervicitis in 56 patients, or 46.7% of cases, condyloma in 2 patients, 1.7% of cases, CIN 1 in 6 patients, 5% of cases, CIN2 in 4 patients, soit3,3% of CIN3 and in 3 patients, 2.5% of cases. FCU had a sensitivity of 60%, a specificity of 95.18%, positive predictive value of 69% and a negative predictive value of 93%. The sensitivity of colposcopy was 66% and specificity of59%. Positive predictive value of 18% and a negative predictive value of 92%. For high-grade dysplasia, colposcopy had a sensitivity of 85%, specificity 58%, positive predictive value of 11.3% and a negative predictive value of 98%. Cervical biopsy finds carcinoma in situ in two cases and squamous micro-invasive carcinoma in one case. The treatments were performed essentially a cervical electrocoagulation in 8 patients, a cone biopsy in 7 patients and post conization hysterectomy in 2 patients.
Conclusion: Colposcopy is a harmless and reliable examination to guide the cervical biopsy. Tracks smear, colposcopy and directed biopsy confirmed.

Keywords:

cervical-uterine smears, colposcopy, histology

##plugins.themes.academic_pro.article.details##

References

  1. Registre des Cancers NORD-TUNISIE (données 2004-2006) 2012;10:79-82.
  2. Blohmer JU, Schmalisch G, Klette I, Grineisen Y, Kohls A, GuskiH et al. Increased incidence of cervical intraepithelial neoplasia in young women in the Mitte district, Germany. Acta Cytol 1999;43:195-200.
  3. Pearson SE, Whittaker J, Ireland D, Monaghan JM. Invasive cancer of the cervix after laser treatment. Br J Obstet Gynaecol 1989;96:486-488.
  4. Feldman JG, Chirgwin K, Dehovitz JA. The association of smoking and risk of condyloma acuminatum in women. Obstet Gynecol 1997;89:346-350.
  5. Sigurdsson K. Trends in cervical intra-epithelial neoplasia in Iceland through1995: evaluation of targeted age groups and screening intervals. Acta Obstet Gynecol Scand 1999;78:486-492.
  6. Nanda J, Mc Crory DC, Myers ER, BastianLA, Hasselblad V, Hickey JD et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000;132:810-819.
  7. Cuzick J, Clavel C, Petry KU, Mejier CJ, Ratnam S, Szare et al. Overview of the European and North American studies on HPV testing in primary cervical cancer sceening. Int J Cancer 2006;119:1095-1101.
  8. Agence Nationale d'Accréditation et d'Évaluation en Santé. Conduite à tenir devant un frottis anormal du col de l'utérus: actualisation 2002. Bull Cancer 2002;76:137-141.
  9. Sparkes J, SchoollandM, Barrett B, Kurinczuk JJ, Mitchell KM, Sterrett JF. Trends in the frequency and predictive value of reporting high-grade abnormalities in cervical smears. Cancer Cytopathol 2000;90:215-221.
  10. McCord ML, Stovall TG, Summitt RL, Ling FW. Discrepancy of cervical cytology and colposcopic biopsy: is cervical conization necessary? Obstet Gynecol 1991;77:715-719.
  11. Ramirez EJ, Hernandez E, Miyazawa K. Cervical conization findings in women with dysplastic cervical cytology and normal colposcopy. J Reprod Med 1990;35:359-361.
  12. Joste NE, Crum CP, Cibas ES. Cytologic-histologic correlation for quality control in cervicovaginal cytology: experience with 1582 paired cases. Am J Clin Pathol 1995;103:32-34.
  13. État des lieux et recommandations pour le dépistage du cancer du col de l'utérus en France. HAS synthèse et recommandations 2010.
  14. Crisaru D, Prus D, Lessing J, Levasi H. Connective tissue activating peptide III expression disappears progressively with increased dysplasia in human cervical epithelium. Gynecol Oncol 2000;64:693-698.
  15. Petri KU, Luyten A, Scherbering S. Accuracy of colposcopy management to detect CIN3 and invasive cancer in women with abnormal screening tests: Results from a primary HPV screening project from 2006 to 2011 in Wolfsburg, Germany. Gynecol Oncol 2013;128:282-287.
  16. Boicea A, Patrascu A, Surlin V, Liescu I, Schenker M, Chiutu L. Correlations between colposcopy and histologic results from colposcopically directed biopsy in cervical precancerous lesions . Rev Roum Morphol Embryol 2012;53:735-741.
  17. Kyrgiou M, Tsoumpou I, Vrekoussis T et al. The up-to-date evidence oncolposcopy practice and treatment of cervical intraepithelial neoplasia: the Cochrane colposcopy and cervical cytopathology collaborative group approach. Cancer Treat Rev 2006;32:516-523.